Table 1.
Baseline Characteristics
| Characteristic | Control Group (N = 155) |
Any Hypoglycemia Group (N = 61) |
|---|---|---|
| Male sex | 146 (94.2) | 56 (91.8) |
| Age, years | 64 (56.5–70.5) | 63 (53–69) |
| BMI, kg/m2 | 28.0 (24.2–33.3) | 23.6 (20.9–27.3) |
| Blood glucose on diagnosis, mg/dL | 592.0 (473.0–796.5) | 591 (499–781) |
| Baseline diabetes diagnosis Type 1 diabetes Type 2 diabetes New-onset diabetes |
26 (16.8) 109 (70.3) 20 (12.9) |
28 (45.9) 32 (52.5) 1 (1.6) |
| Comorbidities at baseline Congestive heart failure Hypertension Coronary artery disease Hypothyroidism |
26 (16.8) 122 (78.7) 48 (31.0) 21 (13.5) |
8 (13.1) 52 (85.2) 23 (37.7) 15 (24.6) |
| Medications at baseline Chronic corticosteroid Typical/atypical antipsychotic |
11 (7.1) 9 (5.8) |
2 (3.3) 3 (4.9) |
| Type of event DKA HHS Mixed DKA and HHS |
109 (70.3) 29 (18.7) 17 (11.0) |
49 (80.3) 4 (6.6) 8 (13.1) |
| Inciting event* Insufficient insulin Infection Medication Any infarction |
101 (65.2) 41 (26.5) 11 (7.1) 2 (1.3) |
40 (65.6) 0 (0.0) 3 (4.9) |
| D5W initiated Blood glucose when D5W ordered, mg/dL No D5W initiated |
222 (189–246.5) 12 (7.7) |
220 (168–253.25) 5 (8.2) |
| Resolution of DKA/HHS Time to resolution, hours Diet ordered within 12 hours Transition to SC within 12 hours |
9.0 (5.875–12.5) 114 (73.5) 109 (70.8)† |
7.75 (5.0–12.5) 50 (82.0) 44 (72.1) |
Data are n (%) or median (IQR).
*
Insufficient insulin includes dietary or medication, nonadherence, insulin pump malfunction, or new diagnosis of diabetes; any infarction includes myocardial infarction or stroke.
†
One patient was not transitioned to scheduled SC and resumed oral medications/SSI (not included in this value). D5W, 5% dextrose in water solution.